Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity (original) (raw)
References
Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood Jr DP and Sarkar FH . (2003). Int. J. Oncol., 22, 787–794.
Bertolotti A, Lutz Y, Heard DJ, Chambon P and Tora L . (1996). EMBO J., 15, 5022–5031.
Biegel JA, Conard K and Brooks JJ . (1993). Genes Chromosomes Cancer, 7, 119–121.
Bierer BE, Mattila PS, Standaert RF, Herzenberg LA, Burakoff SJ, Crabtree G and Schreiber SL . (1990). Proc. Natl. Acad. Sci. USA, 87, 9231–9235.
Bjornsti MA and Houghton PJ . (2004). Cancer Cell, 5, 519–523.
Brunn GJ, Hudson CC, Sekulic A, Williams JM, Hosoi H, Houghton PJ, Lawrence Jr JC and Abraham RT . (1997). Science, 277, 99–101.
Chang YC, Lee YS, Tejima T, Tanaka K, Omura S, Heintz NH, Mitsui Y and Magae J . (1998). Cell Growth Differ., 9, 79–84.
Chung J, Kuo CJ, Crabtree GR and Blenis J . (1992). Cell, 69, 1227–1236.
Coenen Schimke JM, Ljungqvist OH, Sarkar G, Conover CA and Sreekumaran Nair K . (1999). Growth Horm. IGF Res., 9, 179–186.
Cory S, Huang DC and Adams JM . (2003). Oncogene, 22, 8590–8607.
Davis DL and Soldin SJ . (2000). Biochem. Biophys. Res. Commun., 277, 325–329.
Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A and Thomas G . (1992). Nature, 359, 162–165.
Erbay E, Park IH, Nuzzi PD, Schoenherr CJ and Chen J . (2003). J. Cell Biol., 163, 931–936.
Frost P, Moatomed F, Hoang B, Shi Y, Gera J, Yan H, Frost P, Gibbons J and Lichtenstein A . (2004). Blood, 104, 4181–4187.
Geoerger B, Kerr K, Tang CB, Fung KM, Powell B, Sutton LN, Phillips PC and Janss AJ . (2001). Cancer Res., 61, 1527–1532.
Gerald WL, Rosai J and Ladanyi M . (1995). Proc. Natl. Acad. Sci. USA, 92, 1028–1032.
Gingras AC, Gygi S, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R and Sonenberg N . (1999). Genes Dev., 13, 1422–1437.
Grolleau A, Bowman J, Pradet-Balade B, Puravs E, Hanash S, Garcia-Sanz JA and Beretta L . (2002). J. Biol. Chem., 277, 22175–22184.
Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW and Geissler EK . (2002). Nat. Med., 8, 128–135.
Hleb M, Murphy S, Wagner EF, Hanna NN, Sharma N, Park J, Li XC, Strom TB, Padbury JF, Tseng YT and Sharma S . (2004). J. Biol. Chem., 279, 31948–31955.
Hosoi H, Dilling MB, Shikata T, Liu LN, Shu L, Ashmun RA, Germain GS, Abraham RT and Houghton PJ . (1999). Cancer Res., 59, 886–894.
Huang S, Bjomsti MA and Houghton PJ . (2003). Cancer Biol. Ther., 2, 222–232.
Huang S and Houghton PJ . (2001). Drug Resist. Update, 6, 378–391.
Huang S and Houghton PJ . (2002). Curr. Opin. Investig. Drugs, 3, 295–304.
Iiboshi Y, Papst PJ, Kawasome H, Hosoi H, Abraham RT, Houghton PJ and Terada N . (1998). J. Biol. Chem., 274, 1092–1099.
Ito E, Honma R, Imai J, Azuma S, Kanno T, Mori S, Yoshie O, Nishio J, Iwasaki H, Yoshida K, Gohda J, Inoue J, Watanabe S and Semba K . (2003). Am. J. Pathol., 163, 2165–2172.
Kim J, Lee K and Pelletier J . (1998a). Oncogene, 16, 1021–1030.
Kim J, Lee K and Pelletier J . (1998b). Oncogene, 16, 1973–1979.
Ladanyi M and Gerald WL . (1994). Cancer Res., 54, 2837–2840.
Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC and Fisher PB . (2002). Oncogene, 21, 708–718.
Lee SB and Haber DA . (2001). Exp. Cell Res., 264, 74–99.
Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Bitterman PB and Polunovsky VA . (2003). J. Biol. Chem., 278, 3015–3022.
Lin TA, Kong X, Haystead TA, Pause A, Belsham G, Sonenberg N and Lawrence Jr JC . (1994). Science, 266, 653–656.
Liu FT, Goff LK, Hao JH, Newland AC and Jia L . (2004). Apoptosis, 9, 377–384.
Lohrum MAE and Vousden KH . (1999). Cell Death Differ., 6, 1162–1168.
Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR, Loda M, Lane HA and Sellers WR . (2004). Nat. Med., 10, 594–601.
Mateo-Lozano S, Tirado OM and Notario V . (2003). Oncogene, 22, 9282–9287.
May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R and Denny CT . (1993). Mol. Cell. Biol., 13, 7393–7398.
Mayerhofer M, Valent P, Sperr WR, Griffin JD and Sillaber C . (2002). Blood, 100, 3767–3775.
Mohiuddin I, Cao X, Fang B, Nishizaki M and Smythe WR . (2001). Cancer Gene Ther., 8, 547–554.
Nishio J, Iwasaki H, Ishiguro M, Ohjimi Y, Fujita C, Yanai F, Nibu K, Mitsudome A, Kaneko Y and Kikuchi M . (2002). Lab. Invest., 82, 1175–1182.
Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN and Reddy ES . (1994). Oncogene, 9, 3087–3097.
Polunovsky VA, Rosenwald IB, Tan AT, White J, Chiang L, Sonenberg N and Bitterman PB . (1996). Mol. Cell. Biol., 16, 6573–6581.
Rauscher III FJ, Benjamin LE, Fredericks WJ and Morris JF . (1994). Cold Spring Harb. Symp. Quant. Biol., 59, 137–146.
Rauscher III FJ, Morris JF, Tournay OE, Cook DM and Curran T . (1990). Science, 250, 1259–1262.
Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G and Abraham RT . (1995). J. Biol. Chem., 270, 815–822.
Sawyer JR, Tryka AF and Lewis JM . (1992). Am. J. Surg. Pathol., 16, 411–416.
Scharnhorst V, van der Eb AJ and Jochemsen AG . (2001). Gene, 273, 141–161.
Schoffstall B, Kataoka A, Clark AN and Chase PB . (2005). J. Pharmacol. Exp. Ther., 312, 12–18.
Sekulic A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM and Abraham RT . (2000). Cancer Res., 60, 3504–3513.
Shen WP, Towne B and Zadeh TM . (1992). Cancer Genet. Cytogenet., 64, 189–191.
Tan A, Bitterman P, Sonenberg N, Peterson M and Polunovsky V . (2000). Oncogene, 19, 1437–1447.
Voorhees PM, Dees EC, O'Neil B and Orlowski RZ . (2003). Clin. Cancer Res., 9, 6316–6325.
Wang JA, Fan S, Yuan RQ, Ma YX, Meng Q, Goldberg ID and Rosen EM . (1999). Int. J. Radiat. Biol., 75, 301–316.
Wang X, Omura S, Szweda LI, Yang Y, Berard J, Seminaro J and Wu J . (1997). Eur. J. Immunol., 27, 2781–2786.
Zhou C, Gehrig PA, Whang YE and Boggess JF . (2003). Mol. Cancer Ther., 2, 789–795.